Company / Gross Margin
Harmony Biosciences Holdings, Inc. Gross Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
77.2%
FY2025
5-year range
73.7% / 80.9%
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
#8 of 28
Health Care
What the data says
At 77.2%, Harmony Biosciences Holdings, Inc.'s gross margin ranks #8 of 28 in the Health Care sector. Gross Margin has declined for 3 consecutive years, from 80.9% in FY2022 to 77.2% in FY2025.
Based on SEC 10-K filings.
77.2% in FY2025 with a 5-year CAGR of +3.5%.
Declined from 79.2% to 77.2% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -3.8pp
- 5-Year Change
- +3.5pp
- 10-Year Change
- -
Sector benchmark
#8 of 28 in Health CareTop 29% of 28This company 77.2% Sector average 60.3%
▼
+28.0% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 1.2% year-over-year.
- Currently 16.9pp above the Health Care sector average.
- Peak gross margin was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 77.2% | -1.2% |
| FY2024 | 78.1% | -1.4% |
| FY2023 | 79.2% | -2.2% |
| FY2022 | 80.9% | +9.8% |
| FY2021 | 73.7% | +0.0% |
| FY2020 | 73.7% | -0.0% |
| FY2019 | 73.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026